Results 121 to 130 of about 8,450,023 (405)
An Iterative Joint Linear-Programming Decoding of LDPC Codes and Finite-State Channels [PDF]
In this paper, we introduce an efficient iterative solver for the joint linear-programming (LP) decoding of low-density parity-check (LDPC) codes and finite-state channels (FSCs). In particular, we extend the approach of iterative approximate LP decoding,
Kim, Byung-Hak, Pfister, Henry D.
core +1 more source
ABSTRACT Background Apolipoprotein ε4 (APOE ε4) is a potent genetic risk factor for Alzheimer's disease (AD). However, its role in cerebral small vessel disease (CSVD) remains unclear. Given the clinical and pathological similarities between CSVD and AD, this study aimed to investigate the associations of APOE ε4 gene dosage with cognitive function and
Tingru Jin +6 more
wiley +1 more source
Joint Image Compression and Encryption Using IWT with SPIHT, Kd-Tree and Chaotic Maps [PDF]
Nasrullah +5 more
openalex +1 more source
The development and evaluation of exercises in meaningful word practice in first grade, [PDF]
Research chapter for this study will be found in Ash, Dorothea: "Development and evaluation of silent reading exercises in grade one" Thesis (M.A.)--Boston ...
Berger, Ruth J. +6 more
core +1 more source
Evaluation of Pediatric Manual Wheelchair Mobility Using Advanced Biomechanical Methods [PDF]
There is minimal research of upper extremity joint dynamics during pediatric wheelchair mobility despite the large number of children using manual wheelchairs.
Aurit, Christine M. +7 more
core +4 more sources
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu +9 more
wiley +1 more source
The construction of a vocabulary test for the intermediate grades, [PDF]
Thesis (M.A.)--Boston ...
Kelly, Dorothy Marie,joint author +3 more
core +1 more source
Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin +2 more
wiley +1 more source

